Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

You may be eligible if

• DISEASE CHARACTERISTICS:
• Histologically or cytologically confirmed primary non-small cell lung cancer, including any of the following:
• * Newly diagnosed selected stage IIIB (T4 lesion due to malignant pleural effusion) disease
• * Newly diagnosed stage IV disease
• * Recurrent disease after prior surgery and/or radiotherapy
• Any of the following cellular subtypes are allowed:
• * Adenocarcinoma
• * Large cell carcinoma
• * Squamous cell carcinoma
• * Unspecified carcinoma
• Enrolled on protocol JMTO-LC00-03
• PATIENT CHARACTERISTICS:
• Performance status
• Zubrod 0-1
• Life expectancy
• Not specified
• Hematopoietic
• Not specified
• Hepatic
• Not specified
• Renal
• Not specified
• PRIOR CONCURRENT THERAPY:
• Radiotherapy
• See Disease Characteristics
• Surgery
• See Disease Characteristics